Insider Transactions in Q4 2023 at Evelo Biosciences, Inc. (EVLO)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 08
2023
|
Marella Thorell Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,811
-7.52%
|
$0
$0.33 P/Share
|
|
Nov 08
2023
|
Simba Gill President & CEO |
SELL
Open market or private sale
|
Direct |
172
-0.96%
|
$0
$0.33 P/Share
|
|
Nov 08
2023
|
Duncan Mc Hale Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,103
-15.45%
|
$0
$0.33 P/Share
|
|
Nov 08
2023
|
Mark Bodmer CSO, President of R&D |
SELL
Open market or private sale
|
Direct |
3,163
-10.95%
|
$0
$0.33 P/Share
|
|
Nov 07
2023
|
Marella Thorell Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+21.26%
|
-
|
|
Nov 07
2023
|
Simba Gill President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,172
+6.14%
|
-
|
|
Nov 07
2023
|
Duncan Mc Hale Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+24.45%
|
-
|
|
Nov 07
2023
|
Mark Bodmer CSO, President of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
6,625
+18.65%
|
-
|
|
Nov 02
2023
|
Marella Thorell Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,999
-18.54%
|
$0
$0.33 P/Share
|
|
Nov 02
2023
|
Duncan Mc Hale Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,854
-33.53%
|
$0
$0.33 P/Share
|
|
Nov 02
2023
|
Mark Bodmer CSO, President of R&D |
SELL
Open market or private sale
|
Direct |
6,854
-23.53%
|
$0
$0.33 P/Share
|
|
Nov 01
2023
|
Marella Thorell Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+36.69%
|
-
|
|
Nov 01
2023
|
Duncan Mc Hale Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+37.95%
|
-
|
|
Nov 01
2023
|
Mark Bodmer CSO, President of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+30.03%
|
-
|